Rivastigmine in the treatment of Alzheimer's disease: an update.

Clinical interventions in aging

Volumn 2, Issue 1, 2007, Pages 17-32

  Onor, Maria Luisa ^a   Trevisiol, Marianna ^a   Aguglia, Eugenio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; RIVASTIGMINE;

ALZHEIMER DISEASE; BEHAVIOR; CLINICAL TRIAL; DIFFUSE LEWY BODY DISEASE; DRUG EFFECT; HUMAN; REVIEW;

ALZHEIMER DISEASE; BEHAVIOR; CLINICAL TRIALS AS TOPIC; HUMANS; LEWY BODY DISEASE; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES;

EID: 38449088916     PISSN: 11769092     EISSN: None     Source Type: Journal    
DOI: 10.2147/ciia.2007.2.1.17     Document Type: Review

References (72)